Despite its current technical prowess, a user recently reported contact dermatitis from their Apple Watch Ultra 2, an issue they had not encountered with previous models, highlighting a surprising chink in Apple's wearable armor, according to reddb. Even premium device iterations can present fundamental user comfort challenges, diverging from expected meticulous design standards.

The Apple Watch Ultra 2 offers robust technical specifications, including an S9 SiP with a 64-bit dual-core processor and a 4-core Neural Engine, according to Apple Support. However, it is encountering user issues and incremental health updates, yet Apple is reportedly developing a major redesign and FDA-reviewed health features for a model years away.

Apple appears to be trading immediate, iterative improvements for a long-term, transformative leap in health technology, potentially leaving current users in a holding pattern.

What We Know About Apple Watch Health Features

  • A user reported contact dermatitis from their Apple Watch Ultra 2, an issue not encountered with previous models, according to reddb.
  • Apple is reportedly preparing a "major redesign" and "significant upgrade to sensing functions" for the Ultra 4, expected in 2026, according to Memeburn.
  • A new high blood pressure notification feature for the Apple Watch is reportedly under FDA review, utilizing the optical heart-rate sensor to analyze blood vessel response, according to Memeburn.
  • The Apple Watch Ultra 2 incorporates an S9 SiP with a 64-bit dual-core processor and a 4-core Neural Engine, according to Apple Support.
  • The device's display features 326 pixels per inch, according to Apple Support.

The Long Game: Ultra 4 and FDA-Approved Health

The Apple Watch Ultra 4, expected in 2026, with a major redesign and significant upgrade to sensing functions, according to Memeburn. Apple's ambitious plan is a strategic pivot from consumer fitness tracking to regulated medical diagnostics, positioning future devices as serious health tools. A new high blood pressure notification feature is reportedly under FDA review, using the optical heart-rate sensor to analyze blood vessel response.